Vistagen Therapeutics Inc (NAS:VTGN)
$ 3.19 0.04 (1.27%) Market Cap: 86.31 Mil Enterprise Value: -21.37 Mil PE Ratio: 0 PB Ratio: 0.81 GF Score: 29/100

Q2 2024 Vistagen Therapeutics Inc Earnings Call Transcript

Nov 09, 2023 / 10:00PM GMT
Release Date Price: $2.89 (-6.17%)
Operator

Good day, everyone, and welcome to today's Vistagen fiscal year 2024 second quarter corporate update conference call. (Operator Instructions) Please note this call is being recorded. I will be standing by if you should need any assistance. It is now my pleasure to turn the conference over to Mark McPartland. Please go ahead, sir.

Mark McPartland
Vistagen Therapeutics, Inc. - SVP, IR

Thank you, Travis. Good afternoon, everyone, and welcome to Vistagen's fiscal year 2024 second quarter corporate update conference call and webcast. This afternoon, we filed our quarterly report and issued a press release providing an overview of our progress last quarter. We encourage you to review the release, which can be found on the Investors section of the Vistagen website.

During today's call, we will make forward-looking statements regarding our business based on our current expectations and information. Forward-looking statements speak only as of today and except as required by law, we do not assume any duty to update in the future any forward-looking statement

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot